IMA (STOCKS)
ImageneBio, Inc. Common Stock
$5.410000
+0.670000 (+14.14%)
Prev close: $4.740000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kristin Yarema
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $68.14M
- Employees
- 15
- P/E (TTM)
- -0.94
- P/B (TTM)
- 0.41
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
2
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-1.42 | $-1.46 | +0.0411 | +2.81% |
|
Sep 2025 (Q3)
|
$-2.91 | $-1.29 | -1.6172 | -125.09% |
|
Jun 2025 (Q2)
|
$-0.72 | $-1.70 | +0.9768 | +57.57% |
|
Mar 2025 (Q1)
|
$-2.16 | $-2.55 | +0.3852 | +15.13% |
Financial Statements
| Revenues | $800.00K |
| Benefits Costs and Expenses | $46.50M |
| Costs And Expenses | $46.50M |
| Nonoperating Income/Loss | $2.75M |
| Operating Expenses | $49.25M |
| Depreciation and Amortization | $399.00K |
| Research and Development | $28.53M |
| Other Operating Expenses | $20.33M |
| Operating Income/Loss | -$48.45M |
| Income/Loss From Continuing Operations After Tax | -$45.35M |
| Income/Loss From Continuing Operations Before Tax | -$45.70M |
| Income Tax Expense/Benefit | -$350.00K |
| Income Tax Expense/Benefit, Current | -$350.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$45.35M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$45.35M |
| Net Income/Loss Available To Common Stockholders, Basic | -$52.40M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $7.05M |
| Preferred Stock Dividends And Other Adjustments | $7.05M |
| Basic Earnings Per Share | -$9.64 |
| Diluted Earnings Per Share | -$9.64 |
| Basic Average Shares | 4,870,906 |
| Assets | $152.98M |
| Current Assets | $140.29M |
| Noncurrent Assets | $12.69M |
| Fixed Assets | $0.00 |
| Liabilities | $19.84M |
| Current Liabilities | $11.23M |
| Accounts Payable | $1.44M |
| Wages | $2.89M |
| Other Current Liabilities | $6.91M |
| Noncurrent Liabilities | $8.60M |
| Equity | $133.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $133.14M |
| Liabilities And Equity | $152.98M |
| Net Cash Flow From Operating Activities | -$47.84M |
| Net Cash Flow From Operating Activities, Continuing | -$47.84M |
| Net Cash Flow From Investing Activities | -$5.81M |
| Net Cash Flow From Investing Activities, Continuing | -$5.81M |
| Net Cash Flow From Financing Activities | $135.47M |
| Net Cash Flow From Financing Activities, Continuing | $135.47M |
| Exchange Gains/Losses | $604.00K |
| Net Cash Flow | $82.41M |
| Net Cash Flow, Continuing | $81.81M |
| Comprehensive Income/Loss | -$45.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$45.29M |
| Other Comprehensive Income/Loss | $58.00K |